Has Regeneron Pharmaceuticals, Inc. (regn) Bottomed Out?

Discussion in 'Investment Charts' started by Chartman, May 11, 2018.

    May 11, 2018
  1. Chartman

    Chartman Senior Investor

    Joined:
    Sep 2017
    Posts:
    703
    Likes Received:
    8
    It has been a downwards spiral for the REGN share price since August 2017 but a spike today suggests it might be worth a look?

    Also interesting to see that the majority of analysts are negative on the stock, even though the price is well below all of their target prices. Fancy a swim against the tide?

    [​IMG]

    10 May 18
    Cramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects CNBC

    8 May 18
    Edited Transcript of REGN earnings conference call or presentation 3-May-18 12:30pm GMT Thomson Reuters StreetEvents

    6 May 18
    3 Reasons Regeneron Stock Could Start Climbing Again Motley Fool
     
    Chartman, May 11, 2018
    Chartman, May 11, 2018
    #1
    2. May 12, 2018
  2. gowiththeflow

    gowiththeflow Senior Investor

    Joined:
    Jul 2017
    Posts:
    1,041
    Likes Received:
    9
    Wow that spike followed through!

    I think that markets dont fully understand pharmas and the risk/reward ratio associated with new treatments. I think a collective fund picking up bombed out pharmas which still have decent drugs to sell could make a fortune for someone :)
     
    gowiththeflow, May 12, 2018
    gowiththeflow, May 12, 2018
    #2
    3. May 13, 2018
  3. longtermbull

    longtermbull Administrator Staff Member

    Joined:
    Nov 2016
    Posts:
    1,720
    Likes Received:
    20
    There are a lot of pharma groups that have bombed after their headline drugs/treatments disappointed (even just very slightly) which can sometimes mask other up and coming treatments. A pooled fund of "bombed out" pharmas with some underlying strength might be an interesting option for contrarian investors?
     
    longtermbull, May 13, 2018
    longtermbull, May 13, 2018
    #3
    4. May 14, 2018
  4. gowiththeflow

    gowiththeflow Senior Investor

    Joined:
    Jul 2017
    Posts:
    1,041
    Likes Received:
    9
    As pharma shares are deemed higher risk than "normal shares" it seems that investors want a greater potential reward which means pushing them to levels where they are seriously undervalued before investors show any interest. Even the ones with decent potential can get dragged into undervalued territory.
     
    gowiththeflow, May 14, 2018
    gowiththeflow, May 14, 2018
    #4
    5. May 17, 2018
  5. JR Ewing

    JR Ewing Super Moderator Staff Member

    Joined:
    Feb 2014
    Posts:
    4,950
    Likes Received:
    39
    JR Ewing, May 17, 2018
    JR Ewing, May 17, 2018
    #5
    6. May 18, 2018
  6. gowiththeflow

    gowiththeflow Senior Investor

    Joined:
    Jul 2017
    Posts:
    1,041
    Likes Received:
    9
    Still a long way to go before the new drug can go on sale, and a lot that can still go wrong, but if the market gets the merest whiff that it might be successful these shares should rebound very sharply.
     
    gowiththeflow, May 18, 2018
    gowiththeflow, May 18, 2018
    #6
    7. May 19, 2018
  7. longtermbull

    longtermbull Administrator Staff Member

    Joined:
    Nov 2016
    Posts:
    1,720
    Likes Received:
    20
    This one is going to be very volatile - while tempting to buy at the first sign it is turning, it might be worth waiting a little longer to be sure that the trend has changed. Not one for the faint hearted :)
     
    longtermbull, May 19, 2018
    longtermbull, May 19, 2018
    #7
    8. Jun 3, 2018
  8. gowiththeflow

    gowiththeflow Senior Investor

    Joined:
    Jul 2017
    Posts:
    1,041
    Likes Received:
    9
    Momentum seems to be growing again - a push above $310 would be a very bullish sign, with $350 the next possible stop?
     
    gowiththeflow, Jun 3, 2018
    gowiththeflow, Jun 3, 2018
    #8
Tags:

Share This Page